DIAGNOS : Grants Stock Options 4-Traders

BROSSARD, QUEBEC--(Marketwired - Dec. 2, 2016) - (TSX VENTURE:ADK) - Diagnos Inc. ("DIAGNOS" or "the Company") a leader in the use of artificial intelligence and advanced knowledge extraction techniques is pleased to announce a grant of 500,000 stock options to one of its directors. The exercise price of these options has been established at $0.09 per share. The expiry date to which these options can be exercised has been fixed to December 2, 2021. All monies quoted in this press release shall be stated in lawful money of Canada. Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes.